Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ABACUS FCF INNOV
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
4,017,876
-
Shares change
-
+118,364
-
Total reported value, excl. options
-
$117,748,000
-
Value change
-
+$3,451,226
-
Number of buys
-
7
-
Number of sells
-
-11
-
Price
-
$29.39
Significant Holders of ABACUS FCF ETF TR - ABACUS FCF INNOV (ABOT) as of Q4 2021
19 filings reported holding ABOT - ABACUS FCF ETF TR - ABACUS FCF INNOV as of Q4 2021.
ABACUS FCF ETF TR - ABACUS FCF INNOV (ABOT) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,017,876 shares
.
Largest 10 shareholders include ENVESTNET ASSET MANAGEMENT INC (1,919,499 shares), Donoghue Forlines LLC (633,440 shares), MML INVESTORS SERVICES, LLC (500,337 shares), CONCOURSE FINANCIAL GROUP SECURITIES, INC. (371,129 shares), NewEdge Advisors, LLC (360,574 shares), PRUDENTIAL FINANCIAL INC (74,613 shares), Geneos Wealth Management Inc. (45,888 shares), NEXT Financial Group, Inc (26,516 shares), PARK AVENUE SECURITIES LLC (22,999 shares), and ADVISOR GROUP HOLDINGS, INC. (21,263 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.